OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin
Piatek, C.I, Tagawa, S.T, Wei-Tsai, D, Hanna, D, Weitz, I.C, O’Connell, C, Rochanda, L, Groshen, S, Liebman, H.A
Published in Thrombosis research (01.04.2016)
Published in Thrombosis research (01.04.2016)
Get full text
Journal Article
PF734 PATIENT PREFERENCES FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS OF A PATIENT SURVEY OF RAVULIZUMAB (ALXN1210) AND ECULIZUMAB
Peipert, J.D., Kulasekararaj, A., Gaya, A., Langemeijer, S.M. C., Yount, S., Fernandez, F.A. Gonzalez, Gutierrez, E. Ojeda, Martens, C., Sparling, A., Webster, K.A., Cella, D., Tomazos, I., Ogawa, M., Piatek, C.I., Wells, R., Hill, A., Kaiser, K.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article